Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies - Morse, Gene D; Reichman, Richard C; Fischl, Margaret A; Para, Michael; Leedom, John; Powderly, William; Demeter, Lisa M; Resnick, Lionel; Yiannis Bassiakos; Timpone, Joseph; others (Antiviral research, 2000)